Evidence map›Paper›PMID 37658876›Full record

ArticleAbdominal radiology (New York)2023

Society of abdominal radiology survey of practice patterns in using LI-RADS treatment response criteria in the evaluation of hepatocellular carcinoma post-locoregional treatment.

Rony Kampalath, Mishal Mendiratta-Lala, Sara Lewis, Thad Benefield, Vahid Yaghmai, Lauren Burke

Abstract read
PubMed Publisher
In one paragraph

Article in Abdominal radiology (New York), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Rony KampalathDepartment of Radiological Sciences, University of California Irvine, 101 The City Drive South, Orange, CA, 92868, USA. rkampala@hs.uci.edu.
Mishal Mendiratta-LalaRadiology, University of Michigan School of Medicine, 1500 East Medical Center Drive, UH B2A209R, Ann Arbor, MI, 48109-5030, USA.
Sara LewisDepartment of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1234, New York, NY, 10029-6574, USA.
Thad BenefieldCarolina Mammography Registry, University of North Carolina at Chapel Hill, CB #7510, Bioinformatics Building Room 3125, Chapel Hill, NC, 27599-7515, USA.
Vahid YaghmaiDepartment of Radiological Sciences, University of California Irvine, 101 The City Drive South, Orange, CA, 92868, USA.
Lauren BurkeDepartment of Radiology, University of North Carolina at Chapel Hill School of Medicine, 2000 Old Clinic, CB# 7510, Chapel Hill, NC, 27599, USA.
University of California, Irvine · USUniversity of North Carolina at Chapel Hill · USIcahn School of Medicine at Mount Sinai · USUniversity of Michigan–Ann Arbor · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo examine national trends in the adoption and use of the LI-RADS Treatment Response Algorithm.

methodsMembers of the Society of Abdominal Radiology (SAR) Disease-Focused Panel (DFP) on LI-RADS Treatment Response (LR-TR) of hepatocellular carcinoma (HCC) developed a 15-question survey which was distributed to radiologists at academic and private practice institutions around the USA and Canada. The survey focused on HCC-related practice patterns as well as the adoption and use of the LR-TR algorithm.

resultsOf 122 surveys distributed, a total of 76 radiologists responded (62%). Responders were predominantly from academic centers (85%). Nearly all (96%) participate in multidisciplinary hepatic tumor boards and most (67%) have an active liver transplant program. All responders' institutions perform locoregional therapy for HCC, including radiation-based therapy (TARE and SBRT). There was a preference for use of MRI over CT for follow-up after locoregional therapy. All responders were aware of the LR-TR algorithm and nearly all (92%) used the system in routine practice. Radiologists expressed a need for more visual aids related to the LR-TR system. Multiple respondents requested additional clarity within the LR-TR algorithm regarding the evolution of post-treatment radiation changes over time.

conclusionMost survey participants use the LR-TR algorithm after locoregional therapy for HCC. Future iterations of the algorithm may benefit from increased clarity regarding response after radiation-based therapies. Educational materials should include more visual aids to improve reader understanding.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsPractice Patterns, Physicians'AlgorithmsCanadaHumansMagnetic Resonance ImagingSocieties, MedicalSurveys and QuestionnairesTomography, X-Ray ComputedTreatment OutcomeUnited StatesHCCHepatocellular carcinomaLI-RADS treatment response algorithmLocoregional therapy

Identifiers

PMID37658876
OpenAlexW4386387543

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.